Austin Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$107K Hold
100
0.01% 288
2025
Q3
$76.3K Hold
100
0.01% 309
2025
Q2
$78K Sell
100
-100
-50% -$77.7K 0.01% 303
2025
Q1
$165K Hold
200
0.01% 285
2024
Q4
$154K Hold
200
0.01% 272
2024
Q3
$177K Hold
200
0.02% 255
2024
Q2
$181 Hold
200
﹤0.01% 252
2024
Q1
$156 Sell
200
-9,800
-98% -$6.97M ﹤0.01% 246
2023
Q4
$58 Buy
10,000
+9,900
+9,900% +$5.78M ﹤0.01% 254
2023
Q3
$54 Buy
+100
New +$51.5K ﹤0.01% 183

Other funds holding LLY

Austin Private Wealth's LLY Position: Q4 2025 in Review

Austin Private Wealth increased its Eli Lilly (LLY) stake by 4.7% in Q4 2025, buying an estimated $49.7K and bringing the position to 1,152 shares worth $1.24M. The position accounts for 0.09% of the portfolio, ranked #97.

Austin Private Wealth first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Austin Private Wealth held 1,152 shares of Eli Lilly worth $1.24M as of Q4 2025.
  • Austin Private Wealth bought 52 Eli Lilly shares in Q4 2025, an estimated $49.7K.
  • Eli Lilly made up 0.09% of Austin Private Wealth's portfolio in Q4 2025, its #97 holding.
  • Austin Private Wealth first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Austin Private Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.